Search

everythinglearnresearchcommunity

for

Search:↓

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

PRP injections may improve hair thickness and density in female hair loss patients.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Flavin prevents cataracts in young rats.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Human dermal papilla cell vesicles can reduce skin fibrosis in mice.

Calancardin B may help reduce inflammation in immune cells.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Mutations in hKAP1 genes may cause hereditary hair disorders.

MicroRNAs are important for hair growth regulation, with Dicer being crucial and Tarbp2 less significant.

Permanent hair dye mixtures can irritate and damage the skin.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Nilotinib can cause keratosis pilaris, a skin condition.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

RIPK1 inhibitors might help prevent alopecia areata.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

Pomiferin may improve skin and scalp health by boosting important protein expression.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.